Page last updated: 2024-11-04

temozolomide and Cancer of Pelvis

temozolomide has been researched along with Cancer of Pelvis in 2 studies

Research Excerpts

ExcerptRelevanceReference
" Cases from June 2006 through October 2016 were identified for patients receiving bevacizumab and temozolomide for locally advanced, recurrent or metastatic solitary fibrous tumour or hemangiopericytoma, which is sometimes used to describe tumours arising from the meninges."3.91Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis. ( de Lemos, ML; Kang, I; Schaff, K, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Lemos, ML1
Kang, I1
Schaff, K1
Pinnix, CC1
Fontanilla, HP1
Hayes-Jordan, A1
Subbiah, V1
Bilton, SD1
Chang, EL1
Grosshans, DR1
McAleer, MF1
Sulman, EP1
Woo, SY1
Anderson, P1
Green, HL1
Mahajan, A1

Other Studies

2 other studies available for temozolomide and Cancer of Pelvis

ArticleYear
Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Hemangiopericytoma

2019
Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
    International journal of radiation oncology, biology, physics, 2012, May-01, Volume: 83, Issue:1

    Topics: Abdominal Neoplasms; Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineopl

2012